A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Clinical trial NCT04478994 · TERMINATED
Trial details
- NCT number
- NCT04478994
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-17
- Primary completion
- 2022-11-29
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.